Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,961 total articles
AAR CORP. has signed a multi-year agreement to become the preferred distributor of Woodward's high-demand consumable parts for key commercial aircraft engines, expanding their existing defense market collaboration into the commercial aviation sector. This partnership offers airlines more direct access to critical engine components via AAR's global …
The Gabelli Equity Trust Inc. successfully completed a transferable rights offering, issuing over 31.1 million common shares and raising approximately $155 million in gross proceeds. The offering was oversubscribed by $117 million, indicating strong investor demand. Shares will be issued on or about April 28, 2026.
Kaltura’s CEO Ron Yekutiel is actively using a multilingual, AI-powered digital twin based on the company's Agentic Avatar technology to deliver personalized video communications to employees and customers. This innovation improves communication efficiency and engagement by extending the CEO’s presence digitally across global offices and customers,…
Viasat Inc. announced that Jetstar Airways has chosen Viasat's next-generation AMARA in-flight connectivity solution to equip its refreshed Boeing 787 Dreamliner fleet. The installation will span 11 aircraft and continue through mid-2027, aiming to deliver fast, reliable internet supporting streaming, messaging, and browsing. This move aligns with …
La Rosa Holdings Corp. announced it received a Nasdaq notification for failing to timely file its 2025 Annual Report on Form 10-K, resulting in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company plans to file the report promptly or submit a compliance plan to regain Nasdaq compliance by the deadlines provided. No immediate delisting ac…
SunPower Inc., a U.S.-based solar technology and services company, announced it has secured $41 million by issuing Convertible Senior Secured Notes with a 10% coupon and a 45% conversion premium. The funds will be used for working capital and to pay down approximately $40 million in existing debt through exchanges and conversions. The offering targ…
Kestra Medical Technologies is showcasing its Cardiac Recovery System platform, featuring the ASSURE wearable cardiac defibrillator, at the Heart Rhythm Society 2026 meeting. The company announced FDA approval of an algorithm update that improves patient protection using real-world data. Kestra continues to lead innovations in wearable cardiac medi…
Incannex Healthcare Inc. announced its PSX-001 program aligns with a recent White House Executive Order aimed at accelerating the approval and availability of psychedelic treatments for serious mental illnesses. The company highlighted strong Phase 2 clinical trial results for PSX-001, its oral synthetic psilocybin therapeutic targeting Generalized…
Tempest Therapeutics announced a key manufacturing milestone with the delivery of the TPST-2003 lentiviral vector to its manufacturing partner, supporting pivotal trial development of the dual-targeting CD19/BCMA CAR-T therapy for relapsed/refractory multiple myeloma. Positive interim clinical data show 100% complete response in evaluable patients,…
Commercial Vehicle Group (CVGI) will hold its Q1 2026 earnings call on May 6, 2026, to discuss financial results. The company will release a press release and presentation prior to the call, which will be accessible via webcast.
Axe Compute Inc. announced a significant 36-month enterprise contract valued at approximately $260 million to deliver a dedicated cluster of 2,304 NVIDIA B300 GPUs and AI-focused high-speed storage at a Tier 3 US data center. This largest engagement in the company's history will support large-scale AI model training, fine-tuning, and inference task…
Arcutis Biotherapeutics announced that ZORYVE® (roflumilast) cream has received a strong recommendation with high certainty of clinical evidence in the American Academy of Dermatology's first-ever guidelines for pediatric atopic dermatitis treatment. The guidelines endorse ZORYVE cream for children aged 2 years and older, highlighting its efficacy,…
Preferred Bank reported net income of $31.1 million ($2.53 per diluted share) for Q1 2026, a slight increase year-over-year but a decrease compared to the prior quarter. The results were impacted by a reversal of interest income due to a large loan relationship placed on nonaccrual status, rate cuts by the Federal Reserve, and lower noninterest inc…
Twin Disc, Inc., a designer and manufacturer of marine and heavy-duty off-highway power transmission equipment, announced it will release its fiscal 2026 third-quarter earnings on May 6, 2026. The company will host a webcast and conference call to discuss the results and answer investor questions.
Corbus Pharmaceuticals announced that updated clinical data for CRB-701, a next-generation Nectin-4 antibody-drug conjugate for oncology indications, will be presented at ASCO 2026. The data includes efficacy and safety in head and neck squamous cell carcinoma (HNSCC) and cervical cancer patients. The company plans to start a registrational study i…
Immutep Limited announces that a clinical abstract on its immunotherapy drug eftilagimod alfa has been accepted for poster presentation at the ASCO 2026 Annual Meeting. The data highlights the drug’s ability to activate lymphocytes rapidly and sustain immune response, with markers correlating to improved overall survival in metastatic cancer patien…
Humacyte, Inc., a Nasdaq-listed biotechnology company specializing in bioengineered human tissues, has appointed Jim Mercadante as Chief Commercial Officer. With over 25 years of healthcare commercial experience, Mercadante will lead the expansion of Symvess, the company's first FDA-approved acellular tissue engineered vessel (ATEV), currently mark…
MiMedx Group, Inc., a leader in wound care and regenerative medicine, announced it will release its first quarter 2026 financial results after market close on April 29, 2026, followed by a webcast and conference call with senior management to discuss operating and financial performance.
LiveOne (Nasdaq: LVO) announced strategic financial milestones including elimination of $15 million+ short-term liabilities, resulting in over $13 million in cash savings. The company also expanded its stock conversion program to over $15 million at $7.50 per share, with $8 million already completed, enhancing financial stability and supporting lon…
Wrap Technologies, Inc. announced a five-year contract renewal with the Las Vegas Metropolitan Police Department for continued deployment and support of its WrapReality immersive virtual reality training platform. This strategic renewal highlights the police department's endorsement of the platform's value in enhancing officer decision-making, de-e…
Enphase Energy announced an integration between its IQ Batteries and Evergen's advanced virtual power plant (VPP) orchestration platform, enhancing Australian homeowners' ability to optimize battery use, participate in grid-support programs, and benefit from various state and federal incentives. This collaboration aims to accelerate battery adoptio…
IP Strategy Holdings, Inc. unveiled the Story Global Wallet, a new interface designed to simplify access and interaction with the Story Protocol blockchain ecosystem. The wallet integrates seamlessly with popular wallets like MetaMask and Coinbase Wallet to streamline developer integration and user onboarding. This innovation aims to accelerate ado…
OPKO Health’s subsidiary, ModeX Therapeutics, has begun dosing patients in a Phase 1 clinical trial for MDX2003, a first-in-class tetraspecific T-cell engager antibody designed to treat relapsed or refractory B-cell lymphoma. MDX2003 targets two tumor antigens (CD19 and CD20) along with T-cell activators (CD3 and CD28) to enhance the immune system’…
The Beauty Health Company announced a corporate rebrand to SkinHealth Systems Inc. with the aim of becoming a clinically driven, science-backed medical aesthetics company. The company will continue trading under the ticker SKIN and focus on growing its skin health ecosystem anchored by its flagship Hydrafacial device along with complementary offeri…
PMV Pharmaceuticals has appointed Laurie Stelzer as the new Chair of its Board, succeeding Dr. Rich Heyman, effective after the 2026 Annual Meeting. This leadership transition coincides with the continuation of the PYNNACLE Phase 2 clinical trial of rezatapopt for TP53 Y220C mutated advanced solid tumors, with a planned NDA submission in early 2027…
